BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1711694)

  • 1. The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA.
    Tao P; Zhang X; Quan K
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):130-4. PubMed ID: 1711694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 reverse transcriptase by 5'-triphosphates of 5-substituted uridine analogs.
    Tao PZ; Johansson NG; Stening G; Oberg B; Datema R
    Antiviral Res; 1989 Dec; 12(5-6):269-78. PubMed ID: 2483878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
    Vrang L; Oberg B; Löwer J; Kurth R
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1733-4. PubMed ID: 2472774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
    Im GJ; Tramontano E; Gonzalez CJ; Cheng YC
    Biochem Pharmacol; 1993 Dec; 46(12):2307-13. PubMed ID: 7506027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Rubinek T; Loya S; Shaharabany M; Hughes SH; Clark PK; Hizi A
    Eur J Biochem; 1994 Feb; 219(3):977-83. PubMed ID: 7509281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.
    Lowe DM; Parmar V; Kemp SD; Larder BA
    FEBS Lett; 1991 May; 282(2):231-4. PubMed ID: 1709876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
    Reardon JE; Miller WH
    J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening anti-HIV Chinese materia medica with HIV and equine infectious anemic virus reverse transcriptase.
    Tang X; Chen H; Zhang X; Quan K; Sun M
    J Tradit Chin Med; 1994 Mar; 14(1):10-3. PubMed ID: 7515133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and kinetic characterization of equine infectious anemia virus reverse transcriptase.
    Thomas DA; Furman PA
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1365-71. PubMed ID: 1719980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
    Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
    Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate.
    Cruchaga C; Ansó E; Rouzaut A; Martínez-Irujo JJ
    J Biol Chem; 2006 Sep; 281(38):27744-52. PubMed ID: 16829515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
    Freeman GA; Rideout JL; Miller WH; Reardon JE
    J Med Chem; 1992 Aug; 35(17):3192-6. PubMed ID: 1380561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase.
    Ma QF; Bathurst IC; Barr PJ; Kenyon GL
    J Med Chem; 1992 May; 35(11):1938-41. PubMed ID: 1375962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue.
    Vrang L; Bazin H; Remaud G; Chattopadhyaya J; Oberg B
    Antiviral Res; 1987 Mar; 7(3):139-49. PubMed ID: 2440380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphonoformate inhibits reverse transcriptase.
    Sundquist B; Oberg B
    J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
    Wińska P; Miazga A; Poznański J; Kulikowski T
    Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.
    Abbotts J; Wilson SH
    J Enzyme Inhib; 1992; 6(1):35-46. PubMed ID: 1285301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Bakhanashvili M; Hizi A
    Biochemistry; 1993 Jul; 32(29):7559-67. PubMed ID: 7687876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
    Bakhanashvili M; Hizi A
    Biochemistry; 1994 Oct; 33(40):12222-8. PubMed ID: 7522556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.